FTC - ETF AI Analysis
Top Page
First Trust Large Cap Growth AlphaDEX Fund (FTC)
FTC, the First Trust Large Cap Growth AlphaDEX Fund, earns a solid overall rating driven mainly by strong, growth-focused holdings like Expedia, Expeditors International, SharkNinja, and Dexcom, which show robust financial performance, positive earnings sentiment, and supportive technical trends. However, some holdings such as Pure Storage, Fortinet, and Agilent face bearish or mixed technical signals and high valuations, which introduce risk and slightly weigh on the fund’s rating, especially given the concentration in growth names that can be more sensitive to market swings.
FTC vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.32B
- Region
- North America
- Expense Ratio
- 0.58%
- Beta
- 1.13
- Issuer
- First Trust
- Inception Date
- May 08, 2007
- Dividend Yield
- 0.12%
- Asset Class
- Equity
- Index Tracked
- NASDAQ AlphaDEX Large Cap Growth Index
FTC Summary
FTC is an exchange-traded fund that follows the NASDAQ AlphaDEX Large Cap Growth Index, focusing on large, fast-growing U.S. companies. It spreads your money across many sectors, with a big tilt toward technology and industrials. Well-known holdings include Morgan Stanley and eBay, along with other growth-focused firms. Someone might invest in FTC to seek long-term growth while still getting diversification across many companies and industries. However, because it targets growth stocks and is heavily exposed to sectors like technology, its price can go up and down sharply with changes in the stock market.
How much will it cost me?
FTC has an annual expense ratio of 0.58%, which means you’ll pay about $5.80 per year for every $1,000 invested. This cost is higher than the average ETF because it uses an active, rules-based AlphaDEX strategy rather than simple passive index tracking.
What would affect this ETF?
FTC is heavily tilted toward U.S. large-cap growth stocks in technology, industrials, and health care, so it could benefit if innovation, corporate earnings, and the broader U.S. economy stay strong and investors favor growth companies. On the downside, rising interest rates, economic slowdowns, or tighter regulations on tech and health care could hurt these sectors, and the fund’s focus on growth stocks and its rules-based stock selection may lead to larger swings in performance compared with more diversified ETFs.
FTC Top 10 Holdings
FTC is leaning hard into U.S. tech and growth, with names like AMD, CrowdStrike, and Datadog doing much of the heavy lifting as their momentum in AI, security, and cloud keeps the fund’s engine humming. Dell and Lumentum add to the tech tilt, riding rising demand for infrastructure and data. On the health care side, Illumina and Natera are more of a mixed bag—promising stories but still working through valuation and profitability hurdles, which can occasionally hold the fund back. Overall, it’s a U.S.-centric, growth-first lineup with tech in the driver’s seat.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 SN | SharkNinja, Inc. | 1.02% | $13.08M | $27.66B | 102.83% | 76Outperform |
 EXPE | Expedia | 1.03% | $13.16M | $34.69B | 34.02% | 80Outperform |
 EXPD | Expeditors International | 0.99% | $12.75M | $25.51B | 65.62% | 80Outperform |
 WDAY | Workday | 1.03% | $13.22M | $50.61B | -13.68% | 73Outperform |
 MEDP | Medpace Holdings | 1.00% | $12.86M | $18.72B | 12.17% | 79Outperform |
 CPAY | Corpay Inc | 0.98% | $12.61M | $26.82B | 43.60% | 75Outperform |
 NTAP | NetApp | 0.96% | $12.30M | $42.32B | 82.94% | 76Outperform |
 ILMN | Illumina | 0.92% | $11.81M | $40.68B | 169.50% | 71Outperform |
 A | Agilent | 0.94% | $12.05M | $48.79B | 17.37% | 73Outperform |
 MRNA | Moderna | 0.78% | $9.97M | $79.89B | 662.29% | 59Neutral |
FTC Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FTC, the sentiment is Negative. The current price of 170.62 is below the 20-day moving average (MA) of 177.26, below the 50-day MA of 177.63, and below the 200-day MA of 173.05, indicating a bearish trend. The MACD of -1.61 indicates Positive momentum. The RSI at 38.52 is Neutral, neither overbought nor oversold. The STOCH value of 20.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FTC.
FTC Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| FTC | $170.62 | $195.00(14.29% Upside) | $1.32B | 0.58% | 72Outperform |
 JGRO | $92.27 | $119.32(29.32% Upside) | $9.62B | 0.44% | 73Outperform |
 CNEQ | $37.56 | $53.10(41.38% Upside) | $6.79B | 0.56% | 68Neutral |
 FELG | $42.89 | $56.64(32.06% Upside) | $5.71B | 0.18% | 75Outperform |
 QGRW | $65.97 | $86.95(31.80% Upside) | $3.21B | 0.28% | 75Outperform |
 NULG | $109.05 | $144.28(32.31% Upside) | $3.02B | 0.26% | 73Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FTC | First Trust Large Cap Growth AlphaDEX Fund | 170.62 | 6.03 | 3.66% | |
| JGRO | JPMorgan Active Growth ETF | 92.27 | -4.02 | -4.17% | |
| CNEQ | Alger Concentrated Equity ETF | 37.56 | 1.88 | 5.26% | |
| FELG | Fidelity Enhanced Large Cap Growth ETF | 42.89 | 0.60 | 1.42% | |
| QGRW | WisdomTree U.S. Quality Growth Fund | 65.97 | 6.22 | 10.41% | |
| NULG | Nuveen ESG Large-Cap Growth ETF | 109.05 | 6.87 | 6.72% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.